Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. - Wikidata - wikimedia - TriplyDB

Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection.

Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection.

http://www.wikidata.org/entity/Q34603503

about

Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections Diagnostic accuracy of loop-mediated isothermal amplification in detection of Clostridium difficile in stool samples: a meta-analysis WSES guidelines for management of Clostridium difficile infection in surgical patients Rational Therapy of Clostridium difficile Infections Clostridium difficile: epidemiology, diagnostic and therapeutic possibilities-a systematic review Clostridium difficile Infection in Special High-Risk Populations Fecal microbiota transplantation and emerging applications Fecal transplantation for recurrent Clostridium difficile infection in older adults: a review Prediction tools for unfavourable outcomes in Clostridium difficile infection: a systematic review Clostridium difficile infection: Updates in management.Moving fecal microbiota transplantation into the mainstream.Hematologic diseases: high risk of Clostridium difficile associated diarrhea Clostridium difficile infection in older adults Clinical predictors of recurrent Clostridium difficile infection in out-patients.Clostridium difficile infection in the inflammatory bowel disease patient.Serum mannose-binding lectin concentration, but not genotype, is associated with Clostridium difficile infection recurrence: a prospective cohort study.Direct bilirubin as a prognostic biomarker in enteric fistula patients complicated with sepsis: a case-control study.[Challenges of Clostridium difficile infection].A prediction model for Clostridium difficile recurrence Proceedings of the 2013 A.S.P.E.N. Research workshop: the interface between nutrition and the gut microbiome: implications and applications for human health [corrected].Clostridium difficile in western Romania: unfavourable outcome predictors in a hospital for infectious diseases.Microbiome manipulation with faecal microbiome transplantation as a therapeutic strategy in Clostridium difficile infection A Multi-Center Prospective Derivation and Validation of a Clinical Prediction Tool for Severe Clostridium difficile Infection.Recurrent Clostridium difficile infection and the microbiome.Predictors and outcomes of readmission for Clostridium difficile in a national sample of medicare beneficiaries Recurrent Clostridium difficile infection: From colonization to cure.Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.Novel approaches to treating Clostridium difficile-associated colitis.Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection.Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model Predictors of first recurrence of Clostridium difficile infection: implications for initial management IgG antibody response to toxins A and B in patients with Clostridium difficile infection.Predicting the Risk of Clostridium difficile Infection upon Admission: A Score to Identify Patients for Antimicrobial Stewardship Efforts.Clostridium difficile infection: new insights into management.Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.Coinfection and Emergence of Rifamycin Resistance during a Recurrent Clostridium difficile Infection.Clostridium difficile associated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients with C. difficile infection.Clostridium difficile infection: management strategies for a difficult disease.Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance.Treatment of refractory and recurrent Clostridium difficile infection.

P2860

Q26752760-8977E13F-4022-4C51-989E-900A5760A715 Q26777157-F1F51AF8-4FC3-46AF-9974-56FF5C5431BE Q26795429-CEEDD69D-99CD-47FE-87B0-5F2D3C37700E Q26796548-920FAEDD-EE34-4583-8825-887EB168D66F Q26827693-82DB95FF-AEAB-41E5-A03F-FAD05656988D Q28069414-0040D312-B155-4A0D-B0C4-8E673399492B Q28255756-CF112B2F-0AD3-4D39-952C-0BB84004E390 Q28294828-BE725185-0EC4-4655-9C33-C258C16D6694 Q28732437-38068F64-6B58-4074-BC3D-68BE7EB36640 Q30239988-970C8655-D2A1-4813-8DF1-C3442190DDBB Q31127164-3E1A45FD-74F1-4F4E-876C-61921A2F8FFA Q33718326-F2D60490-2C16-42C5-80F6-E799444016CA Q33771594-01222E76-BE20-4DF9-9F4B-6E4E4A74B77A Q34055615-E6B2AC8B-B9F6-4E5B-9F42-28CDF87FA2BA Q34234668-88387FA8-26B5-4BC6-8B70-3D022A8ED8B4 Q34393517-01E0CDDD-6133-4000-8C3A-88466D8C04A0 Q35017088-8B5CB36F-2DE9-40BA-B907-BAD4FE683A56 Q35017907-120DD3B5-D86B-4369-B514-6BA7B063C247 Q35054817-5BA05908-635A-4A35-BAA6-C718206E9772 Q35079014-4FC68F66-CD4D-4E06-86C6-59C5BF177E3B Q35213257-551848FA-19BF-4A6E-8024-E1B04130C4F3 Q35240464-204A58E6-F0DC-47DA-93DD-54BBB4253F5D Q35532908-54031CC0-023B-4D31-B8E2-0F5337E4CB25 Q35685694-CACFF1D2-FE4B-4678-8342-F54DC80E3773 Q35711361-9144C244-DF59-47C2-8B10-F4CF606C1FAF Q35822541-746408FA-E80E-4C83-9BAD-0C686EBD20FE Q35845324-A58197EA-309C-4E41-A646-9AD960D5AF3F Q35862915-F6157C0D-833B-4C3F-B650-9171247F7E32 Q35867850-BC6AF26A-C8DA-4462-B1E2-AB207C1D2D85 Q36060123-5D348BC3-2C71-435F-8ED1-6C7804FE05A5 Q36071508-489C3EB8-B5C9-4CFD-A828-1B125ABF0E69 Q36191601-594E4A0A-F375-48E1-8F79-58EDEF541554 Q36520055-CF67F1F3-EAF1-4484-82FF-3188C7760141 Q36523440-3D4FB5AA-76FA-4C50-93A3-DAE2558C5F86 Q37334099-0245D341-C226-492D-A5B7-D3E02ABBE10D Q37363397-5E09CE6E-D1E0-4D9C-84B1-A71AD067AC2B Q37391438-19DBC992-8DD0-4420-9A0E-976C74829AF0 Q37519138-33B8D3C7-5977-492C-8F11-C1F8AE3CD77D Q37588248-DE909B4A-D89B-4971-A94C-7777456C4C4F Q37866629-1200105B-A57A-477A-8373-30C5CBAD863A

P2860

Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection.

http://www.wikidata.org/entity/Q34603503

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Prospective derivation and val ...... ostridium difficile infection.

@ast

Prospective derivation and val ...... ostridium difficile infection.

@en

Prospective derivation and val ...... ostridium difficile infection.

@nl

type

label

Prospective derivation and val ...... ostridium difficile infection.

@ast

Prospective derivation and val ...... ostridium difficile infection.

@en

Prospective derivation and val ...... ostridium difficile infection.

@nl

prefLabel

Prospective derivation and val ...... ostridium difficile infection.

@ast

Prospective derivation and val ...... ostridium difficile infection.

@en

Prospective derivation and val ...... ostridium difficile infection.

@nl

P1433

Q34603503-D9A1DC66-B0DB-4EEA-BDAD-CC3A5EF7EEF4

P1476

Q34603503-39095F93-0606-4F4A-865D-1BD93DD73254

P2093

Q34603503-74C2C5BF-7DA3-4C86-A72B-ABB7224C2DF8

Q34603503-800E29D2-11AC-4612-8EAB-BA96B5C3D85E

Q34603503-9551B6F3-F7BF-4A0B-9A9C-96E64F1B3BCE

Q34603503-9C9B5657-EAD9-4F2F-B834-119074145767

Q34603503-AA011C42-C6A3-4E06-BBE1-E1B72D88D448

Q34603503-AA7442B1-E34D-4FFB-AD60-90FF7AB6EF1A

Q34603503-B87B67E1-B7E9-487D-8D91-701646E8C9AB

Q34603503-D174A27A-E91D-41C5-A616-8FEBEEF104E4

Q34603503-E80A3D16-C5D0-4316-98F2-3EA39DF8B204

P304

Q34603503-C066F199-B89B-4A43-AD78-DF530474764F

P31

Q34603503-EAC4749F-13C5-404B-BAA3-CB8E66BDB911

P356

Q34603503-5E0A2ABD-FD37-4AD4-B2C0-A5380C9BF647

P407

Q34603503-3512A43C-9762-42E9-9F3D-7F78F1E6A10C

P433

Q34603503-8C3A51E0-BF64-45FF-9F12-AE9277ADD911

P478

Q34603503-18EEBA45-4B48-4B62-B7EB-ED9C4B448FFD

P577

Q34603503-65CBE1D3-949E-43F8-BACD-3FBBD9FA4EEC

P5875

Q34603503-BF28771D-C9F2-4F4E-A717-E35ECFA12A51

P698

Q34603503-D3746D0A-A736-474A-A016-26074934C4F6

P921

Q34603503-3974D6C0-D8DD-4807-AF48-F84068BF9870

P356

J.GASTRO.2008.12.038

P1433

Gastroenterology

P1476

Prospective derivation and val ...... ostridium difficile infection.

@en

P2093

Ciarán P Kelly

http://www.w3.org/2001/XMLSchema#string

Daniel A Leffler

http://www.w3.org/2001/XMLSchema#string

Hua Xu

http://www.w3.org/2001/XMLSchema#string

Kianoosh Katchar

http://www.w3.org/2001/XMLSchema#string

Lorraine Kyne

http://www.w3.org/2001/XMLSchema#string

Mary Y Hu

http://www.w3.org/2001/XMLSchema#string

Sanjeev Tummala

http://www.w3.org/2001/XMLSchema#string

Seema Maroo

http://www.w3.org/2001/XMLSchema#string

Valley Dreisbach

http://www.w3.org/2001/XMLSchema#string

P304

1206-1214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2008.12.038

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

136

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23931195

http://www.w3.org/2001/XMLSchema#string

P698

19162027

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile